NCT06503926

Brief Summary

Long term impact of COVID 19 vaccination on dizziness-related disability and balance in adolescence

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

December 6, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 16, 2024

Completed
Last Updated

July 16, 2025

Status Verified

July 1, 2025

Enrollment Period

5 months

First QC Date

August 11, 2023

Last Update Submit

July 12, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Impact on Balance

    The pediatric balance scale is used to assess balance (Lowest score =0 " worst"- Maximum score is 56 " Perfect Balance"

    Through study completion, an average of 1 day - 1 year after taking the vaccine

  • Functional Disability

    The Dizziness Handicap Inventory is used to assess functional disability related to dizziness

    Through study completion, an average of 1 day - 1 year after taking the vaccine

Secondary Outcomes (2)

  • Emotional Disability

    Through study completion, an average of 1 day - 1 year after taking the vaccine

  • Physical Disability

    Through study completion, an average of 1 day - 1 year after taking the vaccine

Interventions

Vaccination

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

* Adolescence age range 10-17 * Vaccinated by any available SARS -COV-2 Vaccinations

You may qualify if:

  • Adolescence age range 10-17
  • received a dose or more of an approved COVID-19 vaccine at least one year before the study enrollment.
  • the ability to complete all assessment measures independently.

You may not qualify if:

  • vestibular or neurological disorders diagnosed before vaccination.
  • mixed COVID-19 vaccine types.
  • a history of traumatic brain injury.
  • current use of medications that affect balance.
  • documented COVID-19 infection within three months of assessment.
  • physical limitations that prevented them from completing balance testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sinai University

Ismailia, Ismailia Governorate, 11749, Egypt

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

August 11, 2023

First Posted

July 16, 2024

Study Start

December 6, 2023

Primary Completion

April 30, 2024

Study Completion

July 1, 2024

Last Updated

July 16, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations